Aina Liu
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Traditional Chinese Medicine Analysis
Papers in
-
- RNA modifications and cancer 3
- Circular RNAs in diseases 2
- Cancer-related gene regulation 2
-
- Cancer-related molecular mechanisms research 5
- Co-authors
- Huajun Qu (7 shared papers)Wenjing Gong (6 shared papers)Yuanyuan Hou (4 shared papers)Gang Bai (3 shared papers)Jinyu Xiang (4 shared papers)Miaomiao Yang (2 shared papers)Guoyu Ding (3 shared papers)Wei Zhang (1 shared paper)
- Journals
- Journal of Clinical Oncology (2 papers)Journal of Pharmaceutical and Biomedical Analysis (2 papers)Biochemical and Biophysical Research Communications (1 paper)APL Bioengineering (1 paper)RSC Advances (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Aina Liu
22 papers receiving 310 citations
Peers
Comparison fields: 5 of 55
- Cancer Research 89
- Complementary and alternative medicine 31
- Analytical Chemistry 38
- Pharmaceutical Science 15
- Biochemistry 13
Countries citing papers authored by Aina Liu
This map shows the geographic impact of Aina Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aina Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aina Liu more than expected).
Fields of papers citing papers by Aina Liu
This network shows the impact of papers produced by Aina Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aina Liu. The network helps show where Aina Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Aina Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 48 | |
| 2 | 2019 | 42 | |
| 3 | 2016 | 42 | |
| 4 | 2017 | 28 | |
| 5 | 2020 | 17 | |
| 6 | 2009 | 17 | |
| 7 | 2015 | 16 | |
| 8 | 2021 | 15 | |
| 9 | 2012 | 14 | |
| 10 | 2014 | 9 | |
| 11 | 2019 | 9 | |
| 12 | 2021 | 8 | |
| 13 | 2019 | 8 | |
| 14 | 2017 | 8 | |
| 15 | 2022 | 7 | |
| 16 | 2025 | 5 | |
| 17 | 2022 | 5 | |
| 18 | 2019 | 5 | |
| 19 | 2022 | 3 | |
| 20 | 2024 | 3 |
About Aina Liu
Aina Liu is a scholar working on Molecular Biology, Cancer Research, Oncology, Pulmonary and Respiratory Medicine and Complementary and alternative medicine, having authored 24 papers that have together received 314 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (5 papers), RNA modifications and cancer (3 papers), Phytochemicals and Antioxidant Activities (2 papers), Circular RNAs in diseases (2 papers), Spectroscopy and Chemometric Analyses (2 papers), Cancer-related gene regulation (2 papers), Traditional Chinese Medicine Analysis (2 papers) and Gastrointestinal Tumor Research and Treatment (2 papers). The work is most often cited by research in Cancer Research (89 citations), Complementary and alternative medicine (31 citations), Analytical Chemistry (38 citations), Pharmaceutical Science (15 citations) and Biochemistry (13 citations). Aina Liu has collaborated with scholars based in China and United States. Frequent co-authors include Huajun Qu, Wenjing Gong, Yuanyuan Hou, Gang Bai, Jinyu Xiang, Miaomiao Yang, Guoyu Ding, Wei Zhang, Min Jiang and Ping Sun. Their work appears in journals such as Journal of Clinical Oncology, Journal of Pharmaceutical and Biomedical Analysis, Biochemical and Biophysical Research Communications, APL Bioengineering and RSC Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.